Happy Friday, I hope everyone is having a great week and is looking forward to a relaxing weekend. Here is what I am reading as we wrap up the week:
- A timely article for the weekend – A Landmark Study on the Origins of Alcoholism
- Yesterday was a historic day for biotech IPO’s – Aptinyx, Magenta lead biotech IPO flurry ahead of summer lull – and the activity continues today – Autolus extends the biotech IPO hot streak, adding $150M and bringing 2-day tally to $718M
- 10 Reasons Why Employers — And New Ventures — Won’t ‘Disrupt’ U.S. Healthcare
- In medtech – Deals and M&As this week: Syncona, Medrobotics, Micrima
I had the pleasure of attending the Xconomy event “Bringing Back the Expats” at Riverpark at the Alexandria Center in New York City last night and it was excellent. The panel that included Steve Holtzman of Decibel Therapeutics, Jeremy Levin of Ovid, David Epstein of Flagship and moderated by Jenna Foger of Alexandria did a wonderful job of hitting many topics pertaining to growing the biotech space in NYC. It did not hurt that the view was spectacular as well.